Design, Synthesis and Antitumor Activity Evaluation of Chrysamide B Derivatives
Longqing Zhu,Junfang Li,Xiaohong Fan,Xiaoling Hu,Jinhong Chen,Yonghong Liu,Xiangyong Hao,Tao Shi,Zhen Wang,Quanyi Zhao
DOI: https://doi.org/10.1016/j.bioorg.2021.104828
IF: 5.307
2021-01-01
Bioorganic Chemistry
Abstract:Marine natural products derived from special or extreme environment provide an important source for the development of anti-tumor drugs due to their special skeletons and functional groups. In this study, based on our previous work on the total synthesis and structure revision of the novel marine natural product Chrysamide B, a group of its derivatives were designed, synthesized, and subsequently of which the anti-cancer activity, structureactivity relationships and cellular mechanism were explored for the first time. Compared with Chrysamide B, better anti-cancer performance of some derivatives against five human cancer cell lines (SGC-7901, MGC-803, HepG2, HCT-116, MCF-7) was observed, especially for compound b-9 on MGC-803 and SGC-7901 cells with the IC 50 values of 7.88 +/- 0.81 and 10.08 +/- 1.08 mu M, respectively. Subsequently, cellular mechanism study suggested that compound b-9 treatment could inhibit the cellular proliferation, reduce the migration and invasion ability of cells, and induce mitochondrial-dependent apoptosis in gastric cancer MGC-803 and SGC-7901 cells. Furthermore, the mitochondrial-dependent apoptosis induced by compound b-9 is related with the JAK2/ STAT3/Bcl-2 signaling pathway. To conclude, our results offer a new structure for the discovery of anti-tumor lead compounds from marine natural products.